Predictive pre clinical oncology studies using patient-derived xenograft platforms
29 May 2022
In this video, The Jackson Laboratory presents on the utility of NSG™ mice for engraftment of primary human tumors, providing strategies for using PDX models in predictive preclinical research and an introduction to PDX models for immuno-oncology research.
About the company
The Jackson Laboratory
The Jackson Laboratory is a global leader in preclinical studies and has been driving therapeutic development breakthroughs for over 90 years. With the most innovative preclinical platforms including humanized mice, and services such as dose ranging, toxicity, and efficacy studies, JAX empowers drug developers and researchers worldwide.
Related products
Request Quote for All Products
JAX® Mice and Services
The Jackson LaboratoryTake advantage of our large inventories of common inbred strains and the convenience of having your breeding and drug efficacy needs met by the leading experts in mouse modeling.
